MedTrace Logo

The Influence of Virtual Reality on Blood Parameters

NCT07042178 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-29

No results posted yet for this study

Summary

The goal of this study is to learn what the impact of exposure to virtual reality content is on the levels of stress-related blood values in healthy volunteers. The main question it aims to answer is:

* To compare the levels of stress-related biomarkers before and after relaxing VR-content (Relax Visit);
* To compare the levels of stress-related biomarkers before and after stress-inducing VR-content (Rollercoaster Visit).

Researchers will compare the Relax and Rollercoaster Visit to see if there is a relationship between the relaxing and stress-inducing VR content on stress-related blood values.

Participants will be asked to watch relaxing or stress-inducing VR content for approximately five minutes. Blood will be withdrawn before and after intervention. After 3-5 weeks the study visit will be repeated using the other VR content.

Conditions

  • Virtual Reality Pain Distraction
  • Endocrinology
  • Haematology

Interventions

OTHER

Meditation video at the beach

A virtual reality video consisting of a 5 minute meditation video at te beach.

OTHER

Rollercoaster video

A virtual reality video consisting of a five minute rollercoaster ride.

Sponsors & Collaborators

  • Van Creveldkliniek

    lead OTHER

Principal Investigators

  • Corien L. Eckhardt, MD PhD · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-27
Primary Completion
2026-02-20
Completion
2026-02-20

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07042178 on ClinicalTrials.gov